Written Question · S2W-06891 · Session 2
Further to the answer to question S2W-6071 by Malcolm Chisholm on 5 March 2004, what the reasons are for its decision not to arrange for cl…
The question
To ask the Scottish Executive, further to the answer to question S2W-6071 by Malcolm Chisholm on 5 March 2004, what the reasons are for its decision not to arrange for clinical trials of the anti-dementia drug memantine (Exiba).
The answer
The Scottish Executiveencourages patient entry into clinical trials but has no locus in setting theseup.
In the Official Report
No contribution in the Official Report cites S2W-06891 by reference.